Downloads
Datasheet: Low Solubility Compounds
For tackling the bioavailability challenges of BCS (Biopharmaceutical Classification System) class II and IV compounds, proven formulation development, analytical and manufacturing capabilities are available at Patheon's facilities. A variety of approaches are often needed to improve the bioavailability of low solubility BCS class II and IV compounds. Patheon's Pharmaceutical Development Services combines biopharmaceutics knowledge, preformulation data, and manufacturing technologies with statistical Design of Experiments to overcome bioavailability challenges.
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get access to this piece of content and thousands of additional articles and product reviews across our entire network of sites.
